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1 Introduction
One of the most frequent and most severe
maternal complications in patients undergoing
anesthesia in connection with cesarean section
is aspiration of acid gastric contents leading to
the development of a syndrome (MENDELSON'S)
which is characterized by bronchospasm, pro-
gressive respiratory insuffiency, hypotonia and
pulmonary edema [10, 12]. The severity of the
syndrome depends on the volume and acidity
of the aspirate [13]. The prevention of the
syndrome has been based on reduction of the
gastric content and its neutralization prior to
induction of anesthesia.
Fasting and aspiration do not ensure an empty
stomach. Administration of oral antacids for
neutralization of the gastric contents is not
advisable since aspiration of antacids causes a
syndrome similar to that following aspiration
of acid gastric contents [6].
Cimetidine administered prior to induction of
anesthesia has been demonstrated to be
effective for the neutralization of gastric con-
tents in both non-obstetric [11] and obstetric
patients [12]. The placental transfer of
cimetidine and its effect, if any, on the infants
are poorly understood [9].
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2 Material and method
The investigation was divided into two parts.
Both parts were approved by the local ethical
committee.
1. Primarily a prospective double-blind in-
vestigation comprising 39 consecutive patients
undergoing cesarean section was carried out.
Thirty-two patients underwent emergency ce-
sarean section, and seven patients had elective
cesarean sections. The indications appear in
Tab. I. Twenty patients received cimetidine
400 mg (100 mg/ml, Tagamet®) intramuscularly
of a mean of 75 minutes (30—195 minutes,
range) before delivery. The remaining 19
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patients were given 0.9% NaCl. After injection
all patients were monitored with a
cardiotocograph (HEWLETT-PACKARD, model
8030 A). The two groups did not differ in age,
weight, parity or duration of pregnancy.
Tab. I. Distribution of indications for cesarean section
in both groups. In some patients there were more than
one indications.
Indications NaCl Cimetidine
Fetal distress
Breech presentation
Placental insuffiency
Placental abruption
, Cephalopelvic disproportion
Prior cesarean section
Prolonged labor
Others
3
9
2
0
3
1
3
1
9
7
2
1
0
0
2
0
Number of patients 19 20
After delivery the infants were placed in an
incubator and observed continously, par-
ticularly for heart rate and respiratory function.
For birth weight below 2500 g or in cases of
severe intrauterine asphyxia, the infants were
monitored with a cardioscope. Two hours after
delivery K, Na, pH, Pco2, HCO^ and glucose
levels were determined from capillary blood
samples. During the second 24-hour period of
life, fasting glucose was determined, and the
infants underwent a complete physical and
neurological examination by a pediatrician who
repeated this examination at discharge.
2. In another study, eight patients with
uncomplicated pregnancies were included.
These patients did not participate in the first
part of the study, and they underwent elective
cesarean section because of breech presentation
or prior cesarean section. One to two hours
prior to delivery the patients received
cimetidine 400 mg intramuscularly. At delivery
samples of maternal venous blood were
obtained together with venous cord blood
samples for determination of the serum
cimetidine concentration (SK & F Research
Laboratories). One, thi^e and five hours after
delivery blood samples from the infants were
taken for determination of the serum con-
centration of cimetidine. The lower limits for
quantitative determination of serum con-
centration of cimetidine was 0.03 mg/1. In a few
cases only 1 ml of whole blood could be drawn
from the infant, and in such cases, the lower
limit of quantitation was fixed at 0.3 mg/1.
All patients in both experiments were delivered
under general anesthesia, as previously de-
scribed [12]. Statistical analyses were performed
using the Mann-Whitney rank-sum test for
unpaired data and the X2-test.
3 Results
1. Altogether 20 infants were delivered in the
control group, and in the cimetidine group
there were 21 infants. In the control group 3
patients underwent cesarean section because of
imminent intrauterine asphyxia compared to 9
patients in the cimetidine group (0.2 > p >
0.1). In the cimetidine group, three infants with
Apgar scores below 7 at one minute were
delivered, as compared to one infant in the
control group.
In the patients with abnormal cardiotocogräph-
ic tracings, no alterations or new changes were
observed after injection. Observed changes are
listed in Tab. II. After delivery no arrhythmias,
or signs of respiratory depression were
observed in the infants, and the values of K,
Na, pH, Pco2, HCO J and glucose were nearly
identical in the two groups (Tab. III). The
differences are non-significant (p > 0.05). No
extreme individual values were seen.
: Tab. II. Abnormalities in cardiotocography in both
groups. Some patients had several abnormalities.
Cardiotocography NaCl Cimetidine
Normal
Reduced variability
Late decelerations
Bradycardia
Absent variability
15
2
2
0
0
10
5
6
2
2
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Tab. III. Results of capillary blood samples from the
infants two hours after delivery in both groups.
NaCl Cimetidine
Na (mmol/1)
K (mol/1)
pCO2 (kpa)
pH
HCOJ
glucose (mmol/1)
140 ±4
4.5 + 0.4
5.7 ± 0.9
7.37 + 0.04
23.1 + 1.3
3.7 + 0.7
138 + 5
4.8 + 0.5
5.6 + 0.8
7.38 + 0.04
23.4 + 1.0
3.4 + 0.7
No signs of early cerebral changes were
observed in any of the infants. All infants were
found to be normal during the physical and
neurological examination.
2. The evaluation of placental transfer of
cimetidine revealed a concentration ratio of 3:1
between maternal venous blood and venous
cord blood (Tab. IV). In 50 per cent of the
infants, there was no trace of cimetidine one
hour after delivery. In one infant cimetidine
was found, but only at a very low and non-
quantifiable level. In the remaining three in-
fants the concentration ratio averaged 0.7 when
measured one hour after delivery as compared
to the value of venous cord blood. Subsequent
samples at 3 and 5 hours after delivery showed
no trace of cimetidine.
None of the 8 infants presented abnormal
findings after birth, and all had normal APGAR
scores. The average birth weight was 3340 g.
4 Discussion
Cimetidine is a histamine H2 receptor an-
tagonist which is well known for the treatment
of peptic ulcer where it blocks gastric acid
secretion. Histamine H2 receptors are present
in many organs including the heart and the
uterus. Animal experiments have not revealed
any influence of cimetidine on the contractility
pattern of the uterine muscles [2] and, following
a single bolus injection, no electrocardiographic
changes were observed [5]; however, ar-
rhythmias have been described following re-
peated doses administered to already ill and
hypovolemic patients [3].
During the study, no pathological changes re-
lated to cimetidine were found in the con-
tractility pattern of the uterus, the
cardiotocographic tracings or blood samples
from the infants. In the infants with low APGAR
scores one minute after delivery, changes in-
dicating severe intrauterine asphyxia were
found prior to injection. The somewhat higher
frequency of infants with low APGAR scores in
the cimetidine group may be explained by the
higher frequency of imminent fetal death as an
indication for cesarean section in this group.
All the infants had normal APGAR scores after
5 minutes and presented no early cerebral
symptoms. To judge the condition of the
newborns, we chosed the value for the APGAR
score at 1 minute since this value has been
found to correlate well with the values for pH,
Tab. IV. Values for serum concentration of cimetidine (mg/1). Those results marked " are from blood samples with
less than 1 ml whole blood (quantitation limit (0.3 mg/1). ND: Cimetidine could not be detected.
Patient
1
2
3
4
5
6
7
8
Maternal
venous blood
1.61
1.00
2.29
1.36
3.44
3.17
3.54
1.86
Venous
cord blood
0.65
0.76
0.63
0.47
1.15
0.84
0.89
0.47
Venous blood from
1 h
0.51
0.61"
0.35"
ND
<0.03
ND"
ND
ND
infant
2 h
<0.03
ND"
ND"
ND"
ND
ND"
ND
ND"
3 h
ND
ND"
ND"
ND
ND
ND"
ND
ND"
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Pco2 and base excess in umbilical artery blood
[4]. McGowAN [9] found no effect of cimetidine
on normal labor or any perinatal effects after
intravenous administration of 200 mg of
cimetidine. Others have reported similar results,
although their groups were selected [8, 14].
In healthy adults most of the cimetidine is
excreted unchanged in the urine, and the half-
life of elimination is about 2 hours [7]. Similar
conditions were observed in a premature infant
who received cimetidine because of hem-
orrhagic gastritis [1]. In order to obtain exact
values for the rate of elimination of cimetidine
in the infants, we should have determined the
cimetidine concentration in arterial cord blood;
however, in only 50% of the infants was there
'detectable amounts of cimetidine one hour after
delivery, and in none was? detected after 2 hours.
This indicates rapid elimination. ZIEMNIAK et
al. [15] found a half-life for cimetidine of 2.1
to 2.4 hours in two full-term infants.
Regarding the placental transfer of cimetidine,
a fairly constant maternal/cord blood ratio of
approximately 3 : 1 was found. McGowAN [9]
found a ratio of 2 : 1 with very great variations.
Hence, since no changes in the course of
delivery or perinatal effects on the infants were
observed after administration of cimetidine, it
is safe to use cimetidine as a prophylactic agent
against the MENDELSON syndrome in patients
undergoing cesarean section. The drug passes
through the placenta at a maternal/cord blood
ratio of about 3:1.
Summary
In a prospective randomized study of 39 consecutive
cesarean sections, 20 patients received cimetidine 400 mg
intramuscularly as a pre-anesthetic, an 19 con-
trolpatients were given NaCl. No perinatal effects on
the infants were observed by cafdiotocography before
delivery, and K, Na, pH, Pco2, HCOJ and glucose
values in capillary blood were nearly identical in the two
groups 2 hours after birth, the difference being non-
significant (p > 0.05). No respiratory effects or
arrhythmias were observed.
In another study comprising 8 elective cesarean sections
in patients with uncomplicated pregnancies, cimetidine
was found to cross the placenta at a maternal/cord blood
ratio of 3 :1. The drug could not be detected in any of
the infants 2 hours after delivery.
Keywords: Cesarean section, cimetidine, placenta, pre-anesthetic agent.
Zusammenfassung
Prämedikation mit Cimetidin bei der Sectio caesarea:
perinatale Effekte, plazentarer Transfer und Elimination
beim Neugeborenen
In einer prospektiven randomisierten Studie wurde bei
20 von 39 Patientinnen mit Sectio caesarea 400 mg Cime-
tidin als Prämedikation i. m. verabreicht. Die Kontroll-
gruppe erhielt NaCl. Cardiotokographisch ergaben sich
keine Hinweise auf eine perinatale Beeinflussung. 2 Stun-
den post partum zeigten die K+-, Na+-, pH-, Pco2-,
HCOJ - und Blutzuckerwerte in beiden Gruppen keine
signifikanten Unterschiede (p > 0.05). Respiratorische
Effekte oder Arrhythmien wurden nicht beobachtet.
In einer weiteren Studie wurden 8 Patientinnen mit
primär indizierter Sectio nach unkompliziertem Schwan-
gerschaftsverlauf erfaßt. Nach dem plazentaren Transfer
betrug das Konzentrationsverhältnis im mütterlichen
Blut bzw. Nabelschnurblut 3:1. Zwei Stunden post
partum war Cimetidin bei keinem der Neugeborenen
mehr nachzuweisen.
Schlüsselwörter: Cimetidin, Plazenta, Prämedikation, Sectio caesarea.
Resume
Cimetidine en pre-anesthesie lors des cesariennes: effets
perinataux sur l'enfant, transfert placentaire et elimina-
tion chez l'enfant
Au cours d'une etude prospective randomisee de 39
cesariennes consecutives, 20 patientes ont regu 400 mg
de cimetidine en pre-anesthesie et les contröles ont
du NaCl. II n'a pas ete observe d'effets perinataux chez
les enfants sur le cardiotocogramme realise avant la
naissance, et les valeurs sur sang capillaire du K, du Na,
du pH, de la Pcoi, des HCOJ et du glucose etaient
pratiquemment identiques dans les 2 groupes apres la
naissance, la difference etant noil significative (p >
J. Perinat. Med. 13 (1985)
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0,05). II n'a pas ete observe d'effets respiratoires ni
d'arythmies.
Dans une autre etude portant sur 8 cesariennes chez des
patientes ayant eu une grossesse sans complication, on
a montre que la cimetidine traverse le placenta avec un
rapport sang maternel/sang du cordon egal ä 3/1, et le
medicament n'a pas pu etre detecte chez les enfants 2
heures apres la naissance.
Mots-cles: Cesarienne, cimetidine, placenta, pre-anesthesie.
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